New research from Stockholm University and Karolinska Institutet shows that viruses interact with proteins in the biological fluids of their host which results in a layer of proteins on the viral surface. This coat of proteins makes the virus more infectious and facilitates the formation of plaques characteristic of neurodegenerative diseases such as Alzheimer’s disease.
Are viruses dead or alive? Well… both. Viruses can only reproduce inside living cells and exploit the cellular machinery of their host to their benefit. However, before entering a host cell, viruses are just nanometer-sized particles, very similar to artificial nanoparticles used in medical applications for diagnosis and therapy. Scientists from Stockholm University and Karolinska Institutet have found that viruses and nanoparticles share another important property; they both become covered by a layer of proteins when they encounter the biological fluids of their host before they find their target cell. This layer of proteins on the surface influence their biological activity significantly.
“Imagine a tennis ball falling into a bowl of milk and cereals. The ball is immediately covered by the sticky particles in the mix and they remain on the ball when you take it out of the bowl. The same thing happens when a virus gets in contact with blood or lung fluids that contain thousands of proteins. Many of these proteins immediately stick to the viral surface forming a so-called protein corona”, Kariem Ezzat of Stockholm University and Karolinska Institutet explains.
Kariem Ezzat and his colleagues studied the protein corona of respiratory syncytial virus (RSV) in different biological fluids. RSV is the most common cause of acute lower respiratory tract infections in young children worldwide, leading up to 34 million cases and 196,000 fatalities each year. “The protein corona signature of RSV in the blood is very different from that in lung fluids. It is also different between humans and other species such as rhesus macaque monkeys, which also can be infected with RSV”, Kariem Ezzat says. “The virus remains unchanged on the genetic level. It just acquires different identities by accumulating different protein coronae on its surface depending on its environment. This makes it possible for the virus to use extracellular host factors for its benefit, and we’ve shown that many of these different coronae make RSV more infectious.”
The researchers from Stockholm University and Karolinska Institutet have also found that viruses such as RSV and herpes simplex virus type 1 (HSV-1) can bind a special class of proteins called amyloid proteins. Amyloid proteins aggregate into plaques that play a part in Alzheimer’s disease where they lead to neuronal cell death. The mechanism behind the connection between viruses and amyloid plaques has been hard to find till now, but Kariem Ezzat and his colleagues found that HSV-1 is able to accelerate the transformation of soluble amyloid proteins into thread-like structures that constitute the amyloid plaques. In animal models of Alzheimer’s disease, they saw that mice developed the disease within 48 hours of infection in the brain. In absence of an HSV-1 infection the process normally takes several months.
“The novel mechanisms described in our paper can have an impact not only on understanding new factors determining how infectious a virus is, but also on devising new ways to design vaccines. In addition, describing a physical mechanism that links viral and amyloid causes of disease adds weight to the increasing research interest in the role of microbes in neurodegenerative disorders such as Alzheimer’s disease and opens up new avenues for treatments.”, Kariem Ezzat of Stockholm University and Karolinska Institutet says.
Learn more: Coat of proteins makes viruses more infectious and links them to Alzheimer’s disease
The Latest on: Neurodegenerative diseases
[google_news title=”” keyword=”neurodegenerative diseases” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Neurodegenerative diseases
- Student links worm behavior to brain diseaseon May 1, 2024 at 5:41 am
For her study, Selvarathinam leveraged the fact that worms have similarities in their genes to humans and predictable behaviors that are easy to study. She proceeded to optimize an experi-mental ...
- Creyon Bio and Cajal Neuroscience Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseaseson May 1, 2024 at 5:41 am
SAN DIEGO and RESEARCH TRIANGLE PARK, N.C. and SEATTLE, May 01, 2024 (GLOBE NEWSWIRE) -- Creyon Bio, Inc. ('Creyon'), a drug development ...
- Why Coya Therapeutics Is A Smart Speculative Buy For Neurodegenerative Diseaseson May 1, 2024 at 3:45 am
Coya Therapeutics is a biotech company developing therapies for neurodegenerative diseases. Read why I deem COYA stock as a good speculative buy.
- To save lives, the FDA must change how it evaluates rare disease treatmentson May 1, 2024 at 2:31 am
To get a green light from the FDA using the traditional approval process, new drugs must undergo two randomized, placebo-controlled clinical trials that confirm safety and clinical benefit — usually ...
- Genes affecting worm behavior found to be relevant to neurological disease in humanson April 30, 2024 at 10:46 pm
As an undergraduate student in The University of Texas at Arlington's Honors College, Hannah Selvarathinam knew she wanted to conduct research. Near the end of her first year at UTA, the Keller native ...
- Brain Autopsies Reveal a Potential New Culprit Behind Alzheimer's Diseaseon April 30, 2024 at 6:50 pm
Analysis of human brain tissue revealed differences in how immune cells behave in brains with Alzheimer's disease compared to healthy brains, indicating a potential new treatment target. University of ...
- Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxiaon April 29, 2024 at 4:54 am
New Evidence Indicates ATH434 can Function as an Iron Chaperone to Redistribute Iron –MELBOURNE, Australia and SAN FRANCISCO, April 29, ...
- Ley ELA: What is Spain's new neurodegenerative disorders law?on April 29, 2024 at 3:23 am
Spain's new 'ALS Law' has been expanded to include all other neurodegenerative disorders such as Alzheimer's, Parkinson's and Huntington's. Here's what you need to know.
- Synthetic nanomaterial could be an effective tool for treating neurodegenerative diseaseson April 26, 2024 at 1:44 am
A newly developed nanomaterial that mimics the behavior of proteins could be an effective tool for treating Alzheimer's and other neurodegenerative diseases.
- Nanomaterial that mimics proteins could be basis for new neurodegenerative disease treatmentson April 25, 2024 at 9:25 am
A newly developed nanomaterial that mimics the behavior of proteins could be an effective tool for treating Alzheimer's and other neurodegenerative diseases. The nanomaterial alters the interaction ...
via Bing News